Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Return on Capital Employed (2017 - 2025)

Dare Bioscience (DARE) has disclosed Return on Capital Employed for 6 consecutive years, with 26.97% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Capital Employed fell 2395.0% year-over-year to 26.97%, compared with a TTM value of 26.97% through Sep 2025, down 2395.0%, and an annual FY2024 reading of 298.34%, down 29578.0% over the prior year.
  • Return on Capital Employed was 26.97% for Q3 2025 at Dare Bioscience, down from 5.4% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 49.49% in Q1 2024 and bottomed at 26.97% in Q3 2025.
  • Average Return on Capital Employed over 5 years is 0.62%, with a median of 2.03% recorded in 2022.
  • Peak annual rise in Return on Capital Employed hit 13061bps in 2021, while the deepest fall reached -81622bps in 2021.
  • Year by year, Return on Capital Employed stood at 1.08% in 2021, then tumbled by -88bps to 2.03% in 2022, then crashed by -468bps to 11.51% in 2023, then skyrocketed by 233bps to 15.3% in 2024, then crashed by -276bps to 26.97% in 2025.
  • Business Quant data shows Return on Capital Employed for DARE at 26.97% in Q3 2025, 5.4% in Q2 2025, and 26.58% in Q1 2025.